Evidence map›Paper›PMID 25641167›Full record

ArticleChemistry & biology2015

Delineating the biosynthesis of gentamicin x2, the common precursor of the gentamicin C antibiotic complex.

Chuan Huang, Fanglu Huang, Eileen Moison, Junhong Guo, Xinyun Jian, Xiaobo Duan, Zixin Deng, Peter F Leadlay, Yuhui Sun

Open access · hybridAbstract read
In one paragraph

Article in Chemistry & biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Glycodiversification of gentamicins throughActa pharmaceutica Sinica. B · 2024
    Article
  11. Article
  12. Article
  13. Facile and selectiveGreen chemistry : an international journal and green chemistry resource : GC · 2022
    Article
  14. Article
  15. Article
  16. Cobalamin-Dependent RadicalACS bio & med chem Au · 2022
    Review
  17. The Atypical Cobalamin-DependentJournal of the American Chemical Society · 2022
    Article
  18. Article
  19. Structure of a BNature · 2022
    Article
  20. Studies of GenK and OxsB, two BMethods in enzymology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Chuan HuangKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People's Republic of China.
Fanglu HuangDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Eileen MoisonDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK.
Junhong GuoKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People's Republic of China.
Xinyun JianKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People's Republic of China.
Xiaobo DuanKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People's Republic of China.
Zixin DengKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People's Republic of China; Hubei Engineering Laboratory for Synthetic Microbiology, Wuhan Institute of Biotechnology, Wuhan 430075, People's Republic of China.
Peter F LeadlayDepartment of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK. Electronic address: pfl10@cam.ac.uk.
Yuhui SunKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, People's Republic of China. Electronic address: yhsun@whu.edu.cn.
Wuhan University · CNUniversity of Cambridge · GB

Funding

Medical Research Council G1001687Medical Research Council MR/M019020/1
6 · The paper itself

Abstract

Gentamicin C complex is a mixture of aminoglycoside antibiotics used worldwide to treat severe Gram-negative bacterial infections. Despite its clinical importance, the enzymology of its biosynthetic pathway has remained obscure. We report here insights into the four enzyme-catalyzed steps that lead from the first-formed pseudotrisaccharide gentamicin A2 to gentamicin X2, the last common intermediate for all components of the C complex. We have used both targeted mutations of individual genes and reconstitution of portions of the pathway in vitro to show that the secondary alcohol function at C-3″ of A2 is first converted to an amine, catalyzed by the tandem operation of oxidoreductase GenD2 and transaminase GenS2. The amine is then specifically methylated by the S-adenosyl-l-methionine (SAM)-dependent N-methyltransferase GenN to form gentamicin A. Finally, C-methylation at C-4″ to form gentamicin X2 is catalyzed by the radical SAM-dependent and cobalamin-dependent enzyme GenD1.

Indexed as

Anti-Bacterial AgentsBiocatalysisEscherichia coliGentamicinsMethylationMethyltransferasesOxidoreductasesRecombinant ProteinsTransaminasesAnti-Bacterial Agentsgentamicin AGentamicinsgentamicin X(2)MethyltransferasesOxidoreductasesRecombinant ProteinsTransaminases

Identifiers

PMID25641167
PMCPMC4340712
OpenAlexW2042137812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.